The cost of the monkeys — a proxy for the volume of clinical trials — is projected to reach Rmb150,000 ($21,000) at the start ...

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to breakthrough innovations and increased deals involving NASDAQ biotech stocks.

Compare the 2026 BSc Microbiology and BSc Biotechnology. To help you choose between a career in genetic engineering and ...

Climate-resilient agriculture uses biotechnology, biofertilizers, biopesticides, genome-edited crops, and AI-driven tools to ...

Many students who enjoy biology dream of working in a laboratory one day. School lessons about cells, diseases, and the human ...

A competitor's setback was Xeris Biopharma 's ( XERS +7.39%) gain on Hump Day. On news that a potential commercial threat to ...

The US Food and Drug Administration (FDA) spent much of 2025 in the spotlight. Through steady drug approvals, renewed ...

Ambros Therapeutics launches with $125M to advance neridronate, a non-opioid therapy for CRPS-1. See how this Phase 3-ready ...

Health-care companies fell, but not by as much as the broad market, amid optimism about the outlook for drug sales next year. Eli Lilly and Novo Nordisk are likely to see strong demand for pill forms ...

Morgans healthcare analysts give Stockhead readers their top picks for 2026 after a tough year for the sector.

A joint research team of the Korea Advanced Institute of Science and Technology (KAIST) and domestic biotechnology firm ...

Shares of the biotech stock fell through their 50-day and 200-day moving averages in volume that was tracking 4,000% above ...